source
- Third death in China’s expedited trials; Merck and Moderna’s cancer vaccine win; and moreWelcome back to Endpoints Weekly! Merck and Moderna dominated the headlines this week with topline results for their personalized cancer vaccine. Check out our team’s detailed analysis on the resul…Endpoints · 16m ago↗ source
- Cure for HIV must protect long-term survivors from loss of benefitsThe authors, a postdoctoral researcher, a long‑term HIV survivor, and the head of a survivor alliance, argue that a future HIV cure should not jeopardize the support systems that have kept many pat…
- Roche's Genentech to invest $750 million to double Oregon manufacturing site